Portland, OR, United States of America

Samantha Savage Stevens

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Oregon Health & Science University. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Samantha Savage Stevens. Retrieved from https://idiyas.com/inventor/samantha-savage-stevens

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Samantha Savage Stevens

Introduction

Samantha Savage Stevens is a prominent inventor based in Portland, OR (US). She has made significant contributions to the field of medical research, particularly in the treatment of acute myeloid leukemia (AML). Her innovative approaches aim to improve the lives of patients suffering from this challenging condition.

Latest Patents

Samantha holds a patent for her invention titled "Treatments for mutations in acute myeloid leukemia." This patent relates to useful methods of treating AML in humans, specifically in the presence of gene mutations. Her work represents a crucial advancement in targeted cancer therapies.

Career Highlights

Samantha is affiliated with Oregon Health & Science University, where she conducts her research and develops her innovative treatments. Her dedication to improving cancer care has positioned her as a key figure in the medical research community.

Collaborations

Samantha has collaborated with notable colleagues, including Jeffrey Tyner and Cristina Tognon. These partnerships have enhanced her research efforts and contributed to the development of effective treatment strategies.

Conclusion

Samantha Savage Stevens exemplifies the spirit of innovation in the medical field, particularly in cancer treatment. Her work continues to inspire advancements that may lead to better outcomes for patients with acute myeloid leukemia.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…